Related Experiment Video
Updated: Jan 7, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
HbA1c and the Severity of Acute Pancreatitis: A Systematic Review and Meta-Analysis
Alexander Ainger1, Stephen Lam1, Bhaskar Kumar1
1Upper Gastrointestinal Surgery, Norwich Medical School, University of East Anglia, Norfolk and Norwich University Hospital NHS Trust, Norwich, GBR.
Background:
HbA1c, a measure of long-term glycaemic control, has been identified as a potential prognostic risk factor for pancreatitis severity, yet there is a paucity of evidence on its association with pancreatitis outcomes in people with and without diabetes. We, therefore, conducted a systematic review and meta-analysis to assess the current body of evidence.
Methods:
Articles from January 1980 to March 2025 were screened using PubMed and the Excerpta Medica database (Embase). Randomised control trials (RCTs), cohort, and case-control studies were permitted for inclusion if they used an appropriate method for both acute pancreatitis (AP) diagnosis and severity classification. Quality assessment was performed using the Newcastle-Ottawa scale (NOS), and random effects models reporting pooled odds ratios (ORs) were estimated in our meta-analyses.
Results:
Our search generated 2,270 results, from which two studies were eligible for inclusion with a total of 1,195 participants. Both studies were deemed to be at low risk of bias. The results of our meta-analyses demonstrated an increased odds of developing severe AP with increased HbA1c levels (OR = 2.14, 95% confidence interval (CI) 1.32-3.48). Elevated HbA1c levels were also found to increase the odds for developing local pancreatic complications (OR = 1.71, 95% CI 1.25-2.34) and systemic complications (pooled OR = 2.82, 95% CI 0.49-16.28).
Conclusions:
Our review suggests that elevated HbA1c levels may increase the likelihood of developing severe AP as well as local and systemic complications. The results of the review are limited due to the small number of included studies. We recommend that large multicentre cohort studies be conducted to further investigate this relationship.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test